O-(D-glucopyranosylidene)amino-Z-N-tert-Butylcarbamate

ID: ALA3785799

Chembl Id: CHEMBL3785799

PubChem CID: 127031611

Max Phase: Preclinical

Molecular Formula: C11H21N3O6

Molecular Weight: 291.30

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)(C)NC(=O)O/N=C1\N[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O

Standard InChI:  InChI=1S/C11H21N3O6/c1-11(2,3)13-10(19)20-14-9-8(18)7(17)6(16)5(4-15)12-9/h5-8,15-18H,4H2,1-3H3,(H,12,14)(H,13,19)/t5-,6-,7+,8-/m1/s1

Standard InChI Key:  NCTRTDKHHIZSSE-OOJXKGFFSA-N

Alternative Forms

  1. Parent:

    ALA3785799

    ---

Associated Targets(Human)

GBA1 Tclin Beta-glucocerebrosidase (14647 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

agl1 Alpha-glucosidase (14 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
lacZ Beta-galactosidase (85 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Alpha-galactosidase (362 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 291.30Molecular Weight (Monoisotopic): 291.1430AlogP: -2.13#Rotatable Bonds: 2
Polar Surface Area: 143.64Molecular Species: NEUTRALHBA: 7HBD: 6
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.41CX Basic pKa: 1.82CX LogP: -2.27CX LogD: -2.27
Aromatic Rings: Heavy Atoms: 20QED Weighted: 0.25Np Likeness Score: 0.65

References

1. Wang J, Wang X, Zhao Y, Ma X, Wan Y, Chen Z, Chen H, Gan H, Li J, Li L, Wang PG, Zhao W.  (2016)  Synthesis and biological evaluation ofd-gluconhydroximo-1,5-lactam and its oxime-substituted derivatives as pharmacological chaperones for the treatment of Gaucher disease,  (2): [10.1039/C5MD00501A]

Source